The digital landscape is buzzing with insights from gastroenterology healthcare professionals (HCPs) on X.com. To help medical affairs teams navigate this wealth of information, StratInt has released a new white paper: “2025 Social Media Trends & Outlook: Gastroenterology Edition.”
This report, powered by Sipherio, an AI-driven analytics platform, delves into 30,000 posts from 100 prominent gastro HCPs in 2024, revealing key trends shaping the future of IBD care.
The white paper highlights several pivotal trends:
- Targeted Therapies: A clear shift towards next-generation biologics and small molecules, with IL-23 inhibitors leading the charge. Discussions around biosimilars are focusing on refinement and accessibility.
- AI Revolution: The transformative potential of AI in IBD management is gaining momentum, with discussions on real-time patient monitoring and AI-driven decision support.
- Non-Invasive Diagnostics: Intestinal ultrasound (IUS) and other non-invasive techniques are gaining traction, promising improved early detection and reduced patient burden.
- Maternal Health in IBD: Studies like PIANO are driving crucial conversations on IBD management during pregnancy, aiming to improve maternal and neonatal outcomes.
- Platform Evolution: While X.com remains central, a shift towards platforms like Bluesky is being observed, requiring careful monitoring of evolving digital engagement strategies.
Download the full white paper below to gain deeper insights and stay ahead of the curve!
